These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
571 related articles for article (PubMed ID: 16909109)
1. Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site. Wallez Y; Cand F; Cruzalegui F; Wernstedt C; Souchelnytskyi S; Vilgrain I; Huber P Oncogene; 2007 Feb; 26(7):1067-77. PubMed ID: 16909109 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation. Lin MT; Yen ML; Lin CY; Kuo ML Mol Pharmacol; 2003 Nov; 64(5):1029-36. PubMed ID: 14573751 [TBL] [Abstract][Full Text] [Related]
3. Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148. Grazia Lampugnani M; Zanetti A; Corada M; Takahashi T; Balconi G; Breviario F; Orsenigo F; Cattelino A; Kemler R; Daniel TO; Dejana E J Cell Biol; 2003 May; 161(4):793-804. PubMed ID: 12771128 [TBL] [Abstract][Full Text] [Related]
4. Tyrosine phosphorylation of VE-cadherin and claudin-5 is associated with TGF-β1-induced permeability of centrally derived vascular endothelium. Shen W; Li S; Chung SH; Zhu L; Stayt J; Su T; Couraud PO; Romero IA; Weksler B; Gillies MC Eur J Cell Biol; 2011 Apr; 90(4):323-32. PubMed ID: 21168935 [TBL] [Abstract][Full Text] [Related]
5. IQGAP1 mediates VE-cadherin-based cell-cell contacts and VEGF signaling at adherence junctions linked to angiogenesis. Yamaoka-Tojo M; Tojo T; Kim HW; Hilenski L; Patrushev NA; Zhang L; Fukai T; Ushio-Fukai M Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):1991-7. PubMed ID: 16763158 [TBL] [Abstract][Full Text] [Related]
6. Association of Csk to VE-cadherin and inhibition of cell proliferation. Baumeister U; Funke R; Ebnet K; Vorschmitt H; Koch S; Vestweber D EMBO J; 2005 May; 24(9):1686-95. PubMed ID: 15861137 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of cultured cell growth by vascular endothelial cadherin (cadherin-5/VE-cadherin). Caveda L; Martin-Padura I; Navarro P; Breviario F; Corada M; Gulino D; Lampugnani MG; Dejana E J Clin Invest; 1996 Aug; 98(4):886-93. PubMed ID: 8770858 [TBL] [Abstract][Full Text] [Related]
8. Promotion of cell spreading and migration by vascular endothelial-protein tyrosine phosphatase (VE-PTP) in cooperation with integrins. Mori M; Murata Y; Kotani T; Kusakari S; Ohnishi H; Saito Y; Okazawa H; Ishizuka T; Mori M; Matozaki T J Cell Physiol; 2010 Jul; 224(1):195-204. PubMed ID: 20301196 [TBL] [Abstract][Full Text] [Related]
9. Impaired VE-cadherin/beta-catenin expression mediates endothelial cell degeneration in dilated cardiomyopathy. Schäfer R; Abraham D; Paulus P; Blumer R; Grimm M; Wojta J; Aharinejad S Circulation; 2003 Sep; 108(13):1585-91. PubMed ID: 12963640 [TBL] [Abstract][Full Text] [Related]
12. Regulation of VE-cadherin linkage to the cytoskeleton in endothelial cells exposed to fluid shear stress. Ukropec JA; Hollinger MK; Woolkalis MJ Exp Cell Res; 2002 Feb; 273(2):240-7. PubMed ID: 11822879 [TBL] [Abstract][Full Text] [Related]
13. Endothelial barrier stabilization by a cyclic tandem peptide targeting VE-cadherin transinteraction in vitro and in vivo. Heupel WM; Efthymiadis A; Schlegel N; Müller T; Baumer Y; Baumgartner W; Drenckhahn D; Waschke J J Cell Sci; 2009 May; 122(Pt 10):1616-25. PubMed ID: 19420236 [TBL] [Abstract][Full Text] [Related]
14. Src-induced tyrosine phosphorylation of VE-cadherin is not sufficient to decrease barrier function of endothelial monolayers. Adam AP; Sharenko AL; Pumiglia K; Vincent PA J Biol Chem; 2010 Mar; 285(10):7045-55. PubMed ID: 20048167 [TBL] [Abstract][Full Text] [Related]
15. VE-cadherin increases the half-life of VEGF receptor 2. Calera MR; Venkatakrishnan A; Kazlauskas A Exp Cell Res; 2004 Oct; 300(1):248-56. PubMed ID: 15383331 [TBL] [Abstract][Full Text] [Related]
16. Soluble VE-cadherin in rheumatoid arthritis patients correlates with disease activity: evidence for tumor necrosis factor α-induced VE-cadherin cleavage. Sidibé A; Mannic T; Arboleas M; Subileau M; Gulino-Debrac D; Bouillet L; Jan M; Vandhuick T; Le Loët X; Vittecoq O; Vilgrain I Arthritis Rheum; 2012 Jan; 64(1):77-87. PubMed ID: 21905018 [TBL] [Abstract][Full Text] [Related]
17. Dynamic phosphorylation of VE-cadherin Y685 throughout mouse estrous cycle in ovary and uterus. Sidibé A; Polena H; Razanajatovo J; Mannic T; Chaumontel N; Bama S; Maréchal I; Huber P; Gulino-Debrac D; Bouillet L; Vilgrain I Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H448-54. PubMed ID: 24858855 [TBL] [Abstract][Full Text] [Related]
18. Tyrosine phosphorylation and the small GTPase rac cross-talk in regulation of endothelial barrier function. Seebach J; Mädler HJ; Wojciak-Stothard B; Schnittler HJ Thromb Haemost; 2005 Sep; 94(3):620-9. PubMed ID: 16268481 [TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of DEP-1/PTPRJ on threonine 1318 regulates Src activation and endothelial cell permeability induced by vascular endothelial growth factor. Spring K; Lapointe L; Caron C; Langlois S; Royal I Cell Signal; 2014 Jun; 26(6):1283-93. PubMed ID: 24583284 [TBL] [Abstract][Full Text] [Related]
20. Modulation of VE-cadherin and PECAM-1 mediated cell-cell adhesions by mitogen-activated protein kinases. Wu J; Sheibani N J Cell Biochem; 2003 Sep; 90(1):121-37. PubMed ID: 12938162 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]